0000939767-20-000055.txt : 20200424 0000939767-20-000055.hdr.sgml : 20200424 20200424202237 ACCESSION NUMBER: 0000939767-20-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200423 FILED AS OF DATE: 20200424 DATE AS OF CHANGE: 20200424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haley Patrick J. CENTRAL INDEX KEY: 0001692954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 20816926 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0103 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_158777414013343.xml FORM 4 X0306 4 2020-04-23 0 0000939767 EXELIXIS, INC. EXEL 0001692954 Haley Patrick J. C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP, Commercial Common Stock 2020-04-23 4 M 0 5000 1.70 A 121873 D Common Stock 2020-04-23 4 S 0 5000 26 D 116873 D Common Stock 23539 I By spouse Common Stock 10648 I By 401(k) Option (right to buy) 1.7 2020-04-23 4 M 0 5000 0 D 2015-07-20 2021-09-18 Common Stock 5000.0 25000 D Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of April 22, 2020. The option, representing the right to purchase a total of 120,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-04-24